NM_000518.5:c.380T>A

Variant summary

Our verdict is Uncertain significance.
+5 Uncertain · Hot
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 5 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateO6_SupportingO7_Moderate

The NM_000518.5(HBB):c.380T>A (p.Val127Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene HBB is a known oncogene (CancerMine: 4 oncogene, 1 driver citations). The gene HBB is a cancer driver gene (CancerMine: 4 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.00000137 (AC=2) in the gnomAD database across 1,461,774 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000224. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (no review stars). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.V127A: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 15106); p.V127G: Uncertain_significance (ClinVar VariationId 15483, 3 stars); p.V127L: other (ClinVar VariationId 15597, 0 stars); p.V127= (synonymous): Likely_benign (ClinVar VariationId 1142046, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

HBB
NM_000518.5 missense

Scores

6
6
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:3O:1

Conservation

PhyloP100: 0.0220

Publications

19 publications found
Variant links:
Genes affected
HBB (HGNC:4827): (hemoglobin subunit beta) The alpha (HBA) and beta (HBB) loci determine the structure of the 2 types of polypeptide chains in adult hemoglobin, Hb A. The normal adult hemoglobin tetramer consists of two alpha chains and two beta chains. Mutant beta globin causes sickle cell anemia. Absence of beta chain causes beta-zero-thalassemia. Reduced amounts of detectable beta globin causes beta-plus-thalassemia. The order of the genes in the beta-globin cluster is 5'-epsilon -- gamma-G -- gamma-A -- delta -- beta--3'. [provided by RefSeq, Jul 2008]
HBB Gene-Disease associations (from GenCC):
  • dominant beta-thalassemia
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, Natera
  • erythrocytosis, familial, 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, PanelApp Australia, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • hemoglobin M disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, ClinGen, PanelApp Australia, Ambry Genetics
  • unstable hemoglobin disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • beta thalassemia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
  • beta-thalassemia and related diseases
    Inheritance: AR Classification: DEFINITIVE Submitted by: Natera
  • beta-thalassemia HBB/LCRB
    Inheritance: AR, SD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics
  • sickle cell disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, Natera
  • sickle cell disease and related diseases
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Heinz body anemia
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hereditary persistence of fetal hemoglobin
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • delta-beta-thalassemia
    Inheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
  • hereditary persistence of fetal hemoglobin-beta-thalassemia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • beta-thalassemia intermedia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • beta-thalassemia major
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin C disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin C-beta-thalassemia syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin E disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin E-beta-thalassemia syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary persistence of fetal hemoglobin-sickle cell disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sickle cell-beta-thalassemia disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sickle cell-hemoglobin c disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sickle cell-hemoglobin d disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • sickle cell-hemoglobin E disease syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000518.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 5 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000022, AC = 2 — absent/extremely rare (O3 moderate [+2])
O6Computational evidence supports deleterious effect
Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect
O7Mutational hotspot or critical domain
Moderate: ≥10 same AA change, or strong functional domain signal; No cancerhotspots.org hit at this position; UniProt domain: 131 pathogenic, 51 benign (OR vs. background: 12.8).; ±8 AA neighbourhood: 11 pathogenic, 5 benign (OR vs. background: 10.5); Variant does not impact splicing — splice-hotspot path not applicable

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000518.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

HBB NM_000518.5
MANE Select
HGVSc / HGVSpc.380T>Ap.Val127Glu
Exon rankExon 3 of 3
missense
Prot: NP_000509.1UniProt: P68871D9YZU5

Ensembl Transcripts

HBB ENST00000335295.4
TSL:1MANE Select
HGVSc / HGVSpc.380T>Ap.Val127Glu
Exon rankExon 3 of 3
missense
Prot: ENSP00000333994.3UniProt: P68871
HBB ENST00000647020.1
HGVSc / HGVSpc.380T>Ap.Val127Glu
Exon rankExon 3 of 3
missense
Prot: ENSP00000494175.1UniProt: P68871
HBB ENST00000883533.1
HGVSc / HGVSpc.380T>Ap.Val127Glu
Exon rankExon 4 of 4
missense
Prot: ENSP00000553592.1UniProt: P68871

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
AF: 0.00000137
AC:2
Hom:0
AN:1461774
Cov:31
GnomAD4 genome
Cov:33
Showing 3 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.00 041958 0.0000150 166888
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
-
-
beta Thalassemia (3)
-
2
-
not provided (2)
1
-
-
Hb SS disease;C0019025:Hereditary persistence of fetal hemoglobin;C0700299:Heinz body anemia;C1840779:METHEMOGLOBINEMIA, BETA TYPE;C1858990:Dominant beta-thalassemia;C1970028:Malaria, susceptibility to;C4693822:Erythrocytosis, familial, 6;CN322236:Beta-thalassemia HBB/LCRB (1)
-
1
-
not specified (1)
-
-
-
HEMOGLOBIN HOFU (1)

Computational Scores

AlphaGenome AVI
Uncertain14
AlphaMissense
Uncertain0.54
BayesDel_addAF
Pathogenic0.40D
BayesDel_noAF
Pathogenic0.34
CADD
Benign13
DANN
Benign0.95
DEOGEN2
Benign0.11T
Eigen
Benign-0.47
Eigen_PC
Benign-0.61
FATHMM_MKL
Benign0.30N
FuncVEP CTI
Pathogenic0.71
GPN-Star LLR
N/A-5.3
GPN-Star score
N/A5.3
LIST_S2
Benign0.46T
M_CAP
Pathogenic0.41D
MetaRNN
Uncertain0.71D
MetaSVM
Uncertain0.26D
Mutation Taster
N/A3/97disease causing (ClinVar)
MutationAssessor
Pathogenic3.5H
PhyloP100
Benign0.022
popEVE
Benign-3.9
PrimateAI
Benign0.32T
PROVEAN
Uncertain-2.6D
REVEL
Pathogenic0.65
Sift
Uncertain0.0010D
Sift4G
Uncertain0.011D
Varity_R
N/A0.51
VESM-3B
Benign-10
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.